Ricci C, Rendina E A, Pescarmona E O, Venuta F, Di Tolla R, Ruco L P, Baroni C D
Department of Thoracic Surgery, University of Rome, La Sapienza, Italy.
Thorax. 1989 Jun;44(6):455-60. doi: 10.1136/thx.44.6.455.
Seventy four cases of thymoma were reclassified into three histological categories--cortical (30), medullary (9), and mixed (34) (the remaining patient had an intrathymic thymoma)--for an investigation of the relation between histological type, clinical behaviour, and long term prognosis. There were significant differences between the histological types in the frequency of myasthenia gravis and of the different tumour stages, the mean age of the patients, and prognosis. Myasthenia gravis occurred more commonly in patients with cortical (33%) and mixed thymoma (35%) than in patients with medullary thymoma (11%). Five, 10, 15, and 20 year actuarial survival was 100% for medullary thymoma; 85%, 76%, 65% and 65% respectively for mixed thymoma; and 52%, 45%, 45%, and 45% for cortical thymoma. Medullary thymoma is a benign tumour arising late in life and there was no mortality in this series after surgery alone. Cortical thymoma usually presented in middle age and must be regarded as malignant; mortality was 50% at five years despite a multidisciplinary approach, with surgery and postoperative radiotherapy in all patients and chemotherapy in selected cases. Mixed thymoma had a better prognosis than cortical thymoma, but must be regarded as potentially malignant. One third of the total patients had died by 10 years despite radical tumour resection.
74例胸腺瘤被重新划分为三种组织学类型——皮质型(30例)、髓质型(9例)和混合型(34例)(其余1例为胸腺内胸腺瘤),以研究组织学类型、临床行为和长期预后之间的关系。不同组织学类型在重症肌无力的发生率、不同肿瘤分期、患者平均年龄及预后方面存在显著差异。重症肌无力在皮质型胸腺瘤(33%)和混合型胸腺瘤(35%)患者中比在髓质型胸腺瘤(11%)患者中更常见。髓质型胸腺瘤的5年、10年、15年和20年精算生存率为100%;混合型胸腺瘤分别为85%、76%、65%和65%;皮质型胸腺瘤为52%、45%、45%和45%。髓质型胸腺瘤是一种发生于晚年的良性肿瘤,本系列中单纯手术后无死亡病例。皮质型胸腺瘤通常在中年出现,必须视为恶性肿瘤;尽管采用了多学科方法,包括所有患者均进行手术和术后放疗,部分病例进行化疗,但5年死亡率仍为50%。混合型胸腺瘤的预后优于皮质型胸腺瘤,但必须视为潜在恶性肿瘤。尽管进行了根治性肿瘤切除,10年时仍有三分之一的患者死亡。